Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study
- 7 March 2002
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart diseaseEuropean Journal of Clinical Investigation, 2001
- Disorders of Iron MetabolismNew England Journal of Medicine, 1999
- Iron and the Genetics of Cardiovascular DiseaseCirculation, 1999
- Iron, Atherosclerosis, and Ischemic Heart DiseaseArchives of internal medicine (1960), 1999
- Iron-mediated cardiovascular injuryVascular Medicine, 1999
- Molecular medicine and hemochromatosis: At the crossroadsGastroenterology, 1999
- Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesisAtherosclerosis, 1998
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2Atherosclerosis, 1998
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.Circulation, 1992